Shanghai, China

Bingcheng Zhou

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignees: Jiangsu Nhwa Pharmaceutical Co., Ltd, Shujing Biopharma Co., Ltd. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Bingcheng Zhou

Introduction

Bingcheng Zhou is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating neuropsychiatric diseases. His work exemplifies the intersection of innovation and practical application in healthcare.

Latest Patents

Bingcheng Zhou holds a patent for a heterocyclic substituted fused γ-carboline derivative, along with its preparation method, intermediate, and uses. This invention is particularly relevant as it relates to a compound structure that can be utilized in the creation of medicaments aimed at treating neuropsychiatric conditions. The patent showcases his commitment to advancing medical science through innovative chemical solutions.

Career Highlights

Throughout his career, Zhou has worked with prominent companies in the pharmaceutical industry, including Shujing Biopharma Co., Ltd and Jiangsu Nhwa Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to significant advancements in drug development.

Collaborations

Some of his notable coworkers include Jun Qin and Xinjian Jiang. Their collaborative efforts have likely played a role in the successful development of his patented innovations.

Conclusion

Bingcheng Zhou's contributions to medicinal chemistry and his innovative patent highlight the importance of research and development in addressing complex health issues. His work continues to inspire advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…